24.29
-2.07
(-7.85%)
As of 10:31:52 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
47,072
47,072
78,592
46,826
72,832
Operating Expense
303,782
303,782
244,122
208,082
173,362
Operating Income
-256,710
-256,710
-165,530
-161,256
-100,530
Net Non Operating Interest Income Expense
37,777
37,777
18,568
6,448
313
Other Income Expense
-4,925
-4,925
--
--
--
Pretax Income
-223,858
-223,858
-146,962
-154,808
-100,217
Net Income Common Stockholders
-223,858
-223,858
-146,962
-154,808
-100,217
Diluted NI Available to Com Stockholders
-223,858
-223,858
-146,962
-154,808
-100,217
Basic EPS
-2.98
--
-2.52
-2.87
-2.09
Diluted EPS
-2.98
--
-2.52
-2.87
-2.09
Basic Average Shares
75,043.99
--
58,365.50
53,933.23
47,989.02
Diluted Average Shares
75,043.99
--
58,365.50
53,933.23
47,989.02
Total Operating Income as Reported
-261,635
-261,635
-165,530
-161,256
-100,530
Total Expenses
303,782
303,782
244,122
208,082
173,362
Net Income from Continuing & Discontinued Operation
-223,858
-223,858
-146,962
-154,808
-100,217
Normalized Income
-218,933
-218,933
-146,962
-154,808
-100,217
Interest Income
38,026
38,026
18,764
6,624
488
Interest Expense
249
249
196
176
175
Net Interest Income
37,777
37,777
18,568
6,448
313
EBIT
-223,609
-223,609
-146,766
-154,632
-100,042
EBITDA
-216,236
-216,236
-143,201
-151,655
-97,645
Reconciled Depreciation
7,373
7,373
3,565
2,977
2,397
Net Income from Continuing Operation Net Minority Interest
-223,858
-223,858
-146,962
-154,808
-100,217
Total Unusual Items Excluding Goodwill
-4,925
-4,925
--
--
--
Total Unusual Items
-4,925
-4,925
--
--
--
Normalized EBITDA
-211,311
-211,311
-143,201
-151,655
-97,645
12/31/2021 - 8/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRIX Nurix Therapeutics, Inc.
10.67
-6.28%
RVMD Revolution Medicines, Inc.
32.91
-4.88%
BPMC Blueprint Medicines Corporation
88.02
-2.22%
IDYA IDEAYA Biosciences, Inc.
14.90
-8.87%
NUVL Nuvalent, Inc.
69.36
-1.56%
RLAY Relay Therapeutics, Inc.
2.3110
-7.19%
ARVN Arvinas, Inc.
6.84
-4.81%
BCYC Bicycle Therapeutics plc
7.54
-6.40%
CGEM Cullinan Therapeutics, Inc.
7.54
-3.58%
RYTM Rhythm Pharmaceuticals, Inc.
49.69
-4.37%